The Use of an MMP Inhibitor, Doxycycline, to Reduce Ovarian Androgen Production and Restore Normal Cycling in Women With Polycystic Ovarian Syndrome
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Doxycycline (Primary)
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- Acronyms MI-PCOS
- 13 Jan 2016 Biomarkers information updated
- 05 Nov 2013 Planned End Date changed from 1 Jun 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 14 Feb 2013 New trial record